BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260811
DTEND;VALUE=DATE:20260814
DTSTAMP:20260515T000956
CREATED:20260429T095446Z
LAST-MODIFIED:20260429T095446Z
UID:43402-1786406400-1786665599@www.pharmajournalist.com
SUMMARY:3rd Lab Ops & Facility Management for Biopharma West Summit
DESCRIPTION:The 3rd Annual Lab Ops & Facility Management for Biopharma West Summit is the West Coast’s dedicated meeting for Lab Operations and Facilities leaders who are being asked to do more with less while keeping scientists productive and R&D environments running at the highest standard. With tighter budgets\, workforce fluctuations\, and rapid pipeline shifts reshaping day-to-day priorities\, this summit is built to help teams maintain operational excellence without compromising safety\, compliance\, or lab uptime. \nTaking place August 11–13\, 2026 in San Diego\, the program brings together 70+ senior leaders across lab operations\, facilities\, scientific services\, and operational support from fast-growing biotechs\, established pharma\, and leading CDMOs/CROs. Expect operator-led discussions centered on the decisions Lab Ops teams are making right now: how to prioritize when everything feels urgent\, how to streamline workflows to protect throughput\, and how to build resilient support models that hold up through organizational change. \nThe agenda tackles the themes shaping lab performance in 2026. You’ll explore how teams are building resilient operations in volatile environments\, integrating automation and applied AI to reduce manual burden and improve decision-making\, and strengthening vendor partnerships and procurement strategy to spend with intention while reducing downtime risk. You’ll also hear how organizations are planning flexible lab and facility footprints that can adapt as research needs evolve\, including approaches to facility transitions and future-proofing infrastructure. \nA key feature is the pre-conference workshop day\, featuring two hands-on sessions designed for immediate application. Workshop A provides a practical toolkit for implementing AI in lab operations\, with proven use cases and guidance for integrating tools into existing systems without disrupting daily work. Workshop B dives into vendor strategy to reduce spend and maximize operational leverage\, with actionable approaches to consolidation\, identifying cost-saving opportunities\, and maintaining service excellence. \nWith 20+ expert speakers\, two interactive workshops\, and 6+ hours of dedicated networking\, this summit is built for honest benchmarking\, meaningful connections\, and takeaways you can implement immediately to maintain excellence and better support scientists. \nTo know more visit: https://ter.li/jgbff6e1
URL:https://www.pharmajournalist.com/event/3rd-lab-ops-facility-management-for-biopharma-west-summit/
LOCATION:The Westgate Hotel\, 1055 2nd Ave\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260819
DTEND;VALUE=DATE:20260822
DTSTAMP:20260515T000956
CREATED:20260430T095421Z
LAST-MODIFIED:20260430T095421Z
UID:43423-1787097600-1787356799@www.pharmajournalist.com
SUMMARY:6th Oligonucleotides for CNS Summit
DESCRIPTION:The 6th Annual Oligonucleotides for CNS Summit USA returns to Boston on 19–21 August 2026\, uniting 160+ leaders across pharma and biotech to accelerate the discovery\, translation and clinical success of CNS‑targeted oligonucleotide therapies. As advances in RNA chemistry\, delivery technologies and clinical evidence unlock previously undruggable CNS targets\, this meeting is the industry’s most focused forum to benchmark what is truly working — and what’s next. \nAcross three highly interactive days\, hear the latest data and strategy from companies including Eli Lilly\, Stoke Therapeutics\, Dyne Therapeutics\, Creyon Bio and Quiver Bioscience\, covering ASOs\, siRNAs\, saRNAs and aptamers. Dive into real‑world challenges around CNS penetration\, BBB shuttles\, intrathecal vs systemic delivery\, splice modulation\, chemistry and conjugation design\, PK/PD translation\, safety and regulatory alignment — all through case studies\, panels\, workshops and roundtables designed for open\, precompetitive discussion. \nWith expanding pipelines\, growing competition and rising expectations for clinical impact beyond rare disease\, this summit offers a uniquely concentrated environment to learn from clinical‑stage programs\, stress‑test your development strategy and connect with the scientists and decision‑makers shaping the future of CNS oligonucleotides. \nFind out more today – https://ter.li/twgv2av6
URL:https://www.pharmajournalist.com/event/6th-oligonucleotides-for-cns-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR